It is a nightmare for ID physicians and microbiologists when it comes to select appropriate antibiotics to fight problematic pathogens like:
- ESBLS
- MDR Pseudomonas
- CRE (carbapenem resistant enterobacteriaceae)
However, currently there are many ABs that are released in the market or under development to fight those hard to treat infections.
The below chart shows the new combinations and other antibiotics and what coverage they offer.
New Antibiotics and their Spectrum
